Emulate, Inc. and LabCorp‘s (NYSE:LH) Covance Drug Development biz inked a deal to collaborate for an organ-on-a-chip preclinical drug evaluation and testing service.
Emulate’s organ-on-a-chip tech is designed to be a predictive model of the human body’s response to diseases and medications.
The companies plan to combine the organ modeling tech with Covance’s expertise of drug development to commercialize the organs-on-a-chip program as a platform to enhance preclinical drug development for other pharma and biotech companies.
The technology’s 1st application will be for a kidney chip, the companies reported. Researchers will evaluate how the chips can assist in drug-transporter interaction assessments, a component of preclinical testing.
Get the full story at our sister site, Drug Delivery Business News.
The post Emulate, LabCorp’s Covance launch organ-on-a-chip program appeared first on MassDevice.
from MassDevice http://ift.tt/2enyptq
Cap comentari:
Publica un comentari a l'entrada